The Role of Transcription Enhancer Factors in Cardiovascular Biology

Trends in Cardiovascular Medicine

Volumn 21, Issue 1, 2011, Pages 1-5

  Jin, Yi ^a   Messmer Blust, Angela F ^a   Li, Jian ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; BETA GALACTOSIDASE; CONNEXIN 40; CONNEXIN 43; DIVERGENT TRANSCRIPTIONAL ENHANCER FACTOR 1; GLYCOGEN SYNTHASE KINASE 3; GLYCOSYLTRANSFERASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYOCYTE ENHANCER FACTOR 2; MYOGENIN; MYOSIN HEAVY CHAIN BETA; PHOSPHOPROTEIN PHOSPHATASE 1; RELATED TRANSCRIPTIONAL ENHANCER FACTOR 1; TRANSCRIPTION FACTOR; TRANSCRIPTIONAL ENHANCER FACTOR 1; TROPONIN T; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN B;

ADENOSINE DIPHOSPHATE RIBOSYLATION; ADRENERGIC STIMULATION; ANGIOGENESIS; BRADYCARDIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CELL DIFFERENTIATION; CELL JUNCTION; DOWN SYNDROME; ELECTROCARDIOGRAM; EMBRYO DEATH; EMBRYO DEVELOPMENT; ENZYME ACTIVITY; GENE EXPRESSION; GENE INACTIVATION; GENETIC REGULATION; GENETIC TRANSCRIPTION; HEART ATRIUM ARRHYTHMIA; HEART CANCER; HEART DEVELOPMENT; HEART EJECTION FRACTION; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HEART OUTPUT; HEART STROKE VOLUME; HEART VENTRICLE HYPERTROPHY; HOMEOSTASIS; HYPERTENSION; KNOCKOUT GENE; MEDICAL RECORD REVIEW; MULTIGENE FAMILY; NUCLEAR MAGNETIC RESONANCE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; REVIEW; UPREGULATION;

ANIMALS; CARDIOVASCULAR DISEASES; DNA-BINDING PROTEINS; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, CARDIAC; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84859479710     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2011.12.009     Document Type: Review

References (46)

1. Appukuttan B., McFarland T.J., Davies M.H., et al. Identification of novel alternatively spliced isoforms of RTEF-1 within human ocular vascular endothelial cells and murine retina. Invest Ophthalmol Vis Sci 2007, 48:3775-3782.
2. Azakie A., Fineman J.R., He Y. Myocardial transcription factors are modulated during pathologic cardiac hypertrophy in vivo. J Thorac Cardiovasc Surg 2006, 132:1262-1271.
3. Azakie A., Lamont L., Fineman J.R., He Y. Divergent transcriptional enhancer factor-1 regulates the cardiac troponin T promoter. Am J Physiol Cell Physiol 2005, 289:C1522-C1534.
4. Azakie A., Larkin S.B., Farrance I.K., et al. DTEF-1, a novel member of the transcription enhancer factor-1 (TEF-1) multigene family. J Biol Chem 1996, 271:8260-8265.
5. Belandia B., Parker M.G. Functional interaction between the p160 coactivator proteins and the transcriptional enhancer factor family of transcription factors. J Biol Chem 2000, 275:30801-30805.
6. Benhaddou A., Keime C., Ye T., et al. Transcription factor TEAD4 regulates expression of Myogenin and the unfolded protein response genes during C2C12 cell differentiation. Cell Death Differ 2012, 19:220-231.
7. Butler A.J., Ordahl C.P. Poly(ADP-ribose) polymerase binds with transcription enhancer factor 1 to MCAT1 elements to regulate muscle-specific transcription. Mol Cell Biol 1999, 19:296-306.
8. Carson J.A., Schwartz R.J., Booth F.W. SRF and TEF-1 control of chicken skeletal alpha-actin gene during slow-muscle hypertrophy. Am J Physiol 1996, 270:C1624-C1633.
9. Chen H.H., Baty C.J., Maeda T., et al. Transcription enhancer factor-1-related factor-transgenic mice develop cardiac conduction defects associated with altered connexin phosphorylation. Circulation 2004, 110:2980-2987.
10. Chen Z., Friedrich G.A., Soriano P. Transcriptional enhancer factor 1 disruption by a retroviral gene trap leads to heart defects and embryonic lethality in mice. Genes Dev 1994, 8:2293-2301.
11. Creemers E.E., Sutherland L.B., McAnally J., et al. Myocardin is a direct transcriptional target of Mef2, Tead and Foxo proteins during cardiovascular development. Development 2006, 133:4245-4256.
12. Gabbiani G. The myofibroblast in wound healing and fibrocontractive diseases. J Pathol 2003, 200:500-503.
13. Gan Q., Yoshida T., Li J., Owens G.K. Smooth muscle cells and myofibroblasts use distinct transcriptional mechanisms for smooth muscle alpha-actin expression. Circ Res 2007, 101:883-892.
14. Gupta M., Kogut P., Davis F.J., et al. Physical interaction between the MADS box of serum response factor and the TEA/ATTS DNA-binding domain of transcription enhancer factor-1. J Biol Chem 2001, 276:10413-10422.
15. Gupta M.P., Amin C.S., Gupta M., et al. Transcription enhancer factor 1 interacts with a basic helix-loop-helix zipper protein, Max, for positive regulation of cardiac alpha-myosin heavy-chain gene expression. Mol Cell Biol 1997, 17:3924-3936.
16. Hesser B.A., Liang X.H., Camenisch G., et al. Down syndrome critical region protein 1 (DSCR1), a novel VEGF target gene that regulates expression of inflammatory markers on activated endothelial cells. Blood 2004, 104:149-158.
17. Jacquemin P., Depetris D., Mattei M.G., et al. Localization of human transcription factor TEF-4 and TEF-5 (TEAD2, TEAD3) genes to chromosomes 19q13.3 and 6p21.2 using fluorescence in situ hybridization and radiation hybrid analysis. Genomics 1999, 55:127-129.
18. Jacquemin P., Hwang J.J., Martial J.A., et al. A novel family of developmentally regulated mammalian transcription factors containing the TEA/ATTS DNA binding domain. J Biol Chem 1996, 271:21775-21785.
19. Jiang S.W., Wu K., Eberhardt N.L. Human placental TEF-5 transactivates the human chorionic somatomammotropin gene enhancer. Mol Endocrinol 1999, 13:879-889.
20. Jin Y., Wu J., Song X., et al. RTEF-1, an upstream gene of hypoxia-inducible factor-1α, accelerates recovery from ischemia. J Biol Chem 2011, 286:22699-22705.
21. Kaneko K.J., Kohn M.J., Liu C., DePamphilis M.L. Transcription factor TEAD2 is involved in neural tube closure. Genesis 2007, 45:577-587.
22. Kariya K., Karns L.R., Simpson P.C. An enhancer core element mediates stimulation of the rat beta-myosin heavy chain promoter by an alpha 1-adrenergic agonist and activated beta-protein kinase C in hypertrophy of cardiac myocytes. J Biol Chem 1994, 269:3775-3782.
23. Karns L.R., Kariya K., Simpson P.C. M-CAT, CArG, and Sp1 elements are required for alpha 1-adrenergic induction of the skeletal alpha-actin promoter during cardiac myocyte hypertrophy: Transcriptional enhancer factor-1 and protein kinase C as conserved transducers of the fetal program in cardiac growth. J Biol Chem 1995, 270:410-417.
24. Li L., Miano J.M., Cserjesi P., Olson E.N. SM22 alpha, a marker of adult smooth muscle, is expressed in multiple myogenic lineages during embryogenesis. Circ Res 1996, 78:188-195.
25. Liu D., Jia H., Holmes D.I., et al. Vascular endothelial growth factor-regulated gene expression in endothelial cells: KDR-mediated induction of Egr3 and the related nuclear receptors Nur77, Nurr1, and Nor1. Arterioscler Thromb Vasc Biol 2003, 23:2002-2007.
26. Liu X., Zhao D., James L., et al. Requirement of the nuclear localization of transcription enhancer factor 3 for proliferation, migration, tube formation, and angiogenesis induced by vascular endothelial growth factor. FASEB J 2011, 25:1188-1197.
27. Liu X., Zhao D., Qin L., et al. Transcription enhancer factor 3 (TEF3) mediates the expression of Down syndrome candidate region 1 isoform 1 (DSCR1-1L) in endothelial cells. J Biol Chem 2008, 283:34159-34167.
28. MacLellan W.R., Lee T.C., Schwartz R.J., Schneider M.D. Transforming growth factor-beta response elements of the skeletal alpha-actin gene: Combinatorial action of serum response factor, YY1, and the SV40 enhancer-binding protein, TEF-1. J Biol Chem 1994, 269:16754-16760.
29. Maeda T., Gupta M.P., Stewart A.F. TEF-1 and MEF2 transcription factors interact to regulate muscle-specific promoters. Biochem Biophys Res Commun 2002, 294:791-797.
30. Maeda T., Mazzulli J.R., Farrance I.K., Stewart A.F. Mouse DTEF-1 (ETFR-1, TEF-5) is a transcriptional activator in alpha 1-adrenergic agonist-stimulated cardiac myocytes. J Biol Chem 2002, 277:24346-24352.
31. Mahoney W.M., Hong J.H., Yaffe M.B., Farrance I.K. The transcriptional co-activator TAZ interacts differentially with transcriptional enhancer factor-1 (TEF-1) family members. Biochem J 2005, 388:217-225.
32. Mar J.H., Ordahl C.P. A conserved CATTCCT motif is required for skeletal muscle-specific activity of the cardiac troponin T gene promoter. Proc Natl Acad Sci USA 1988, 85:6404-6408.
33. Minami T., Horiuchi K., Miura M., et al. Vascular endothelial growth factor- and thrombin-induced termination factor, Down syndrome critical region-1, attenuates endothelial cell proliferation and angiogenesis. J Biol Chem 2004, 279:50537-50554.
34. Nishioka N., Yamamoto S., Kiyonari H., et al. Tead4 is required for specification of trophectoderm in pre-implantation mouse embryos. Mech Dev 2008, 125:270-283.
35. Sawada A., Kiyonari H., Ukita K., et al. Redundant roles of Tead1 and Tead2 in notochord development and the regulation of cell proliferation and survival. Mol Cell Biol 2008, 28:3177-3189.
36. Shie J.L., Wu G., Wu J., et al. RTEF-1, a novel transcriptional stimulator of vascular endothelial growth factor in hypoxic endothelial cells. J Biol Chem 2004, 279:25010-25016.
37. Stewart A.F., Richard C.W., Suzow J., et al. Cloning of human RTEF-1, a transcriptional enhancer factor-1-related gene preferentially expressed in skeletal muscle: Evidence for an ancient multigene family. Genomics 1996, 37:68-76.
38. Stewart A.F., Suzow J., Kubota T., et al. Transcription factor RTEF-1 mediates alpha1-adrenergic reactivation of the fetal gene program in cardiac myocytes. Circ Res 1998, 83:43-49.
39. Szabo C. Cardioprotective effects of poly(ADP-ribose) polymerase inhibition. Pharmacol Res 2005, 52:34-43.
40. Teng A.C., Kuraitis D., Deeke S.A., et al. IRF2BP2 is a skeletal and cardiac muscle-enriched ischemia-inducible activator of VEGFA expression. FASEB J 2010, 24:4825-4834.
41. Tsika R.W., Ma L., Kehat I., et al. TEAD-1 overexpression in the mouse heart promotes an age-dependent heart dysfunction. J Biol Chem 2010, 285:13721-13735.
42. Tsika R.W., Schramm C., Simmer G., et al. Overexpression of TEAD-1 in transgenic mouse striated muscles produces a slower skeletal muscle contractile phenotype. J Biol Chem 2008, 283:36154-36167.
43. Xiao J.H., Davidson I., Matthes H., et al. Cloning, expression, and transcriptional properties of the human enhancer factor TEF-1. Cell 1991, 65:551-568.
44. Xu M., Jin Y., Song Q., et al. The endothelium-dependent effect of RTEF-1 in pressure overload cardiac hypertrophy: Role of VEGF-B. Cardiovasc Res 2011, 90:325-334.
45. Yagi R., Kohn M.J., Karavanova I., et al. Transcription factor TEAD4 specifies the trophectoderm lineage at the beginning of mammalian development. Development 2007, 134:3827-3836.
46. Yasunami M., Suzuki K., Houtani T., et al. Molecular characterization of cDNA encoding a novel protein related to transcriptional enhancer factor-1 from neural precursor cells. J Biol Chem 1995, 270:18649-18654.